vimarsana.com
Home
Live Updates
Medison Pharma Announces the Approvals by Health Canada and
Medison Pharma Announces the Approvals by Health Canada and
Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma
/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...
Related Keywords
Australia ,
United States ,
New Zealand ,
Canada ,
United Kingdom ,
Toronto ,
Ontario ,
Israel ,
Australian ,
Canadian ,
Immunocore Imm ,
Marcus Butler ,
Dara Willis ,
Mark Moyer ,
Victor Papamoniodis ,
Medison Pharma ,
Meir Jakobsohn ,
Therapeutics Goods Administration ,
Tumor Immunotherapy Program ,
Gage Communications ,
Vp International Markets At Medison ,
European Union ,
Corporate Communications ,
Immunocore Holdings ,
Health Canada ,
Head Of Regulatory Affairs At Immunocore ,
Central Eastern Europe ,
Regulatory Affairs ,
Project Orbis ,
Medical Oncologist ,
Skin Medical Oncology Site Lead ,
Princess Margaret Cancer Centre ,
Hazard Ratio ,
Release Syndrome ,
Product Characteristics ,